Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial
Year: 2006
Type: article
Source: Acta Neurologica Scandinavica
Authors: D. L. Sparks, D. J. Connor, M. N. Sabbagh, R. B. Petersen, J. Lopez, P. Browne
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Pfizer
OpenAlex ID: W2023713823
